Novel Pyrazine Analogs of Chalcones: Synthesis and Evaluation of Their Antifungal and Antimycobacterial Activity

Abstract

Abstract:Infectious diseases, such as tuberculosis and invasive mycoses, represent serious health problems. As a part of our long-term efforts to find new agents for the treatment of these diseases, a new series of pyrazine analogs of chalcones bearing an isopropyl group in position 5 of the pyrazine ring was prepared. The structures of the compounds were corroborated by IR and NMR spectroscopy and their purity confirmed by elemental analysis. The susceptibility of eight fungal strains to the studied compounds was tested. The results have been compared with the activity of some previously reported propyl derivatives. The only strain that was susceptible to the studied compounds was Trichophyton mentagrophytes. It was found that replacing a non-branched propyl with a branched isopropyl did not have a decisive and unequivocal influence on the in vitro antifungal activity against T. mentagrophytes. In vitro activity against Trichophyton mentagrophytes comparable with that of fluconazole was exhibited by nitro-substituted derivatives. Unfortunately, no compound exhibited efficacy comparable with that of terbinafine, which is the most widely used agent for treating mycoses OPEN ACCESSMolecules 2015, 20 1105 caused by dermatophytes. Some of the prepared compounds were assayed for antimycobacterial activity against M. tuberculosis H37Rv. The highest potency was also displayed by nitro-substituted compounds. The results of the present study are in a good agreement with our previous findings and confirm the positive influence of electron-withdrawing groups on the B-ring of chalcones on the antifungal and antimycobacterial activity of these compounds.

Five Unprecedented Secondary Metabolites from the Spider Parasitic Fungus Akanthomyces novoguineensis

“…Notably, Compound 4 did not possess any significant cytotoxicity against the tested human cervical carcinoma cell lines, although it has the same functional group as hydroxamic acid derivatives, which have been proposed by Pal and Saha [ 8 ] as powerful anticancer molecules. Moreover, it has also been found that pyrazine and a 2-naphthol bearing glucoside have lost the activity even though pyrazine and its analogues have been reported for decades to possess broad spectrum biological activities [ 9 , 10 , 11 , 12 ]. Even 2-naphthol has been proved to be an efficient moiety for the design of antimicrobial agents [ 13 , 14 ].…”

A screening of the MMV Pathogen Box® reveals new potential antifungal drugs against the etiologic agents of chromoblastomycosis

“…To the best of our knowledge, no antifungal activity has been described for MMV021013. Some studies have identified molecules with in vitro activity against mycotic and tuberculosis agents [33,34], as well as against protozoa and fungi [35]. These observations suggest that these pathogens may share common antimicrobial targets that may propel drug discovery against a broad range of infectious diseases.…”

Synthesis of Pyrazine‐1,3‐thiazine Hybrid Analogues as Antiviral Agent Against HIV‐1, Influenza A (H1N1), Enterovirus 71 (EV71), and Coxsackievirus B3 (CVB3)

“…The compound 1 was synthesized as per the protocol given elsewhere, and the purity of the compound was ascertained on the basis of elemental analysis and by comparing the melting point . The TLC analysis was carried out using benzene:ethyl acetate (7:3) as solvent system, and spots were visualized under UV or iodine chamber.…”